Optimisation of decongestion in acute decompensated heart failure: role of tolvaptan and aquapheresis

被引：0
|
作者：
Chung, E. S. [1 ]
Dadosky, C. [1 ]
Jefferies, J. L. [2 ]
Egnaczyk, G. F. [1 ]
O'brien, T. M. [1 ]
Menon, S. G. [1 ]
机构：
[1] Christ Hosp, Cincinnati, OH 45219 USA
[2] Cincinnati Childrens Hosp Med Ctr, Heart & Vasc Ctr, Cincinnati, OH 45229 USA
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P833
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [41] Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
    Ikeda, Shuntaro
    Ohshima, Kiyotaka
    Miyazaki, Shigehiro
    Kadota, Hisaki
    Shimizu, Hideaki
    Ogimoto, Akiyoshi
    Hamada, Mareomi
    ESC HEART FAILURE, 2017, 4 (04): : 614 - 622
  • [42] Clinical benefit of tolvaptan in patients with acute decompensated heart failure and chronic kidney disease
    Yusuke Uemura
    Rei Shibata
    Kenji Takemoto
    Tomohiro Uchikawa
    Masayoshi Koyasu
    Shinji Ishikawa
    Takayuki Mitsuda
    Ayako Miura
    Ryo Imai
    Satoshi Iwamiya
    Yuta Ozaki
    Tomohiro Kato
    Takanori Miura
    Masato Watarai
    Toyoaki Murohara
    Heart and Vessels, 2016, 31 : 1643 - 1649
  • [43] Predictors of Hypernatremia After Tolvaptan Administration to Patients Hospitalized for Acute Decompensated Heart Failure
    Hata, Reo
    Kawase, Yuichi
    Iwasaki, Keiichiro
    Tada, Takeshi
    Kadota, Kazushige
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S188 - S188
  • [44] Association of renal circulation at acute phase with decongestion level at discharge in patients admitted for acute decompensated heart failure
    Kayama, K.
    Kikuchi, S.
    Sugimoto, T.
    Seo, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [45] Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion
    Chiba, Hiroki
    Seo, Yoshihiro
    Sai, Seika
    Namekawa, Mikiko
    Ishizu, Tomoko
    Aonuma, Kazutaka
    HYPERTENSION RESEARCH, 2019, 42 (03) : 319 - 328
  • [46] Renoprotective effects of tolvaptan in hypertensive heart failure rats depend on renal decongestion
    Hiroki Chiba
    Yoshihiro Seo
    Seika Sai
    Mikiko Namekawa
    Tomoko Ishizu
    Kazutaka Aonuma
    Hypertension Research, 2019, 42 : 319 - 328
  • [47] Decongestion efficacy of "nitrate centered" and moderate "diuretic centered" strategies in acute decompensated heart failure (ADHF)
    Amosova, K. M. Kateryna
    Bezrodnyi, A. B.
    Gorda, I. I.
    Katsytadze, I. Y.
    Sablin, A. V.
    Melnychenko, N. V.
    Bogdan, S. Z.
    Hodakovska, E. V.
    Lazarev, P. O.
    Soloshchenko, A. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 86 - 86
  • [48] Timing of Hemoconcentration During Treatment of Acute Decompensated Heart Failure and Subsequent Survival Importance of Sustained Decongestion
    Testani, Jeffrey M.
    Brisco, Meredith A.
    Chen, Jennifer
    McCauley, Brian D.
    Parikh, Chirag R.
    Tang, W. H. Wilson
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (06) : 516 - 524
  • [49] Full decongestion in acute heart failure therapy
    Buttar, Chandan
    Alai, Hamid
    Matanes, Faris N.
    Cassidy, Mark M.
    Stencel, Jason
    Le Jemtel, Thierry H.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (03): : 182 - 189
  • [50] Investigation of the Efficacy of Tolvaptan Versus Furosemide in Decompensated Heart Failure
    Ando, Tomotaka
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S160 - S160
12345